Biphenyl

Biphenyl

SCHEMBL1913601

OP(O)(=S)Cl.c1ccc(-c2ccccc2)cc1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.53
CYP1A2 P05177 1/20 0.46
MMP3 P08254 1/20 0.46
BCL2L1 Q07817 1/20 0.46
ESR2 Q92731 2/20 0.44
ESR1 P03372 1/20 0.44
ACP3 P15309 2/20 0.43
PTPN5 P54829 2/20 0.41
CA2 P00918 2/20 0.40
CA1 P00915 1/20 0.40
MGLL Q99685 1/20 0.40
MAPK1 P28482 1/20 0.39
CYP3A4 P08684 1/20 0.39
TAAR1 Q96RJ0 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
NOTUM Q6P988 1/20 0.39
MMP8 P22894 1/20 0.39
MMP14 P50281 1/20 0.39
CA14 Q9ULX7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Biphenyl SCHEMBL27653719 0.88 ALDH1A1 (0.60) ALDH1A1CYP1A2MMP3BCL2L1ESR2
Biphenyl SCHEMBL28046879 0.88 ALDH1A1 (0.60) ALDH1A1CYP1A2MMP3BCL2L1CA2
Biphenyl SCHEMBL1913481 0.82 ACP3 (0.54) ALDH1A1CYP1A2MMP3BCL2L1ACP3
Biphenyl SCHEMBL17182196 0.82 ACP3 (0.54) ALDH1A1CYP1A2MMP3BCL2L1ACP3
Biphenyl SCHEMBL11506188 0.82 ACP3 (0.54) ALDH1A1CYP1A2MMP3BCL2L1ACP3
Biphenyl SCHEMBL27595243 0.82 ALDH1A1 (0.53) ALDH1A1CYP1A2MMP3BCL2L1ESR2
Biphenyl SCHEMBL1913599 0.78 ACP3 (0.50) ALDH1A1CYP1A2MMP3BCL2L1ACP3
Biphenyl SCHEMBL27755857 0.77 ALDH1A1 (0.75) ALDH1A1CYP1A2MMP3BCL2L1ESR2
Biphenyl SCHEMBL28098924 0.77 ALDH1A1 (0.90) ALDH1A1CYP1A2MMP3BCL2L1CA2
Biphenyl SCHEMBL263925 0.75 ALDH1A1 (0.60) ALDH1A1MMP3BCL2L1ACP3PTPN5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8883765-B2 Anti-cytomegalovirus activity of artemisinin-derived dimers THE JOHN HOPKINS UNIVERSITY (US) 2014-11-11 US disclosed
US-20130109654-A1 ANTI-CYTOMEGALOVIRUS ACTIVITY OF ARTEMISININ-DERIVED DIMERS THE JOHNS HOPKINS UNIVERSITY (US) 2013-05-02 US disclosed
WO-2011071981-A2 ANTI-CYTOMEGALOVIRUS ACTIVITY OF ARTEMISININ-DERIVED DIMERS THE JOHNS HOPKINS UNIVERSITY (US) 2011-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130109654-A1 ANTI-CYTOMEGALOVIRUS ACTIVITY OF ARTEMISININ-DERIVED DIMERS EIF2AK2, MAVS, PARP16 ALDH1A1 800/4885CYP1A2 1762/4885MMP3 3280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.